GABRG2 rs6495446: Understanding This Genetic Variant
The rs6495446 variant is located within the GABRG2 gene, which plays a critical role in brain signaling. Research associates this gene with a spectrum of epilepsy syndromes and febrile seizures, though the specific impact of this individual variant is a subject of ongoing study.
What each genotype means
Common genetic background
This is the most common genotype for this variant in the general population. Research into GABRG2-related epilepsy focuses on rare, pathogenic mutations rather than this common variant, meaning this genotype is generally considered to have no significant impact on your individual risk for epilepsy or febrile seizures.
This is the major allele genotype and is found in the vast majority of the global population.
Common genetic background
This genotype represents a common variation in the GABRG2 gene. Current scientific literature does not identify this specific common variant as a primary cause of epilepsy or febrile seizures, which are typically associated with rare, high-impact mutations in this gene. It is considered a normal part of human genetic diversity.
This heterozygous genotype is found at varying frequencies across global populations but is considered a common genetic variation.
Common genetic background
This genotype is a common variation observed in the GABRG2 gene. There is no evidence in current research to suggest that carrying this specific genotype increases your risk for neurological conditions or epilepsy. Clinical concerns regarding GABRG2 are generally reserved for rare, pathogenic mutations that alter protein function.
This genotype is present in a significant portion of the population, though its exact frequency varies by ancestry.
What is rs6495446 and Where is it Located?
The rs6495446 variant is a single nucleotide polymorphism (SNP) situated within the GABRG2 gene. In genetics, a SNP represents a variation at a single position in a DNA sequence among individuals. The GABRG2 gene provides instructions for creating the gamma-2 subunit of the GABA-A receptor, a protein complex that acts as a primary inhibitory neurotransmitter receptor in the human brain. By sitting within this gene, rs6495446 is positioned in a region that influences how these receptors are built or function. Scientists study such variants to understand how subtle changes in DNA sequence might correlate with differences in neurological health or susceptibility to specific conditions. Because this variant is common, it is frequently analyzed in large-scale genomic studies to determine if it contributes to the genetic architecture of complex traits or disorders.
The Role of the GABRG2 Gene
The GABRG2 gene is essential for the proper function of the central nervous system. It encodes the gamma-2 subunit of the GABA-A receptor, which is a ligand-gated chloride channel. These receptors are responsible for inhibitory neurotransmission, essentially acting as the 'brakes' of the brain by reducing neuronal excitability. When GABA binds to these receptors, they allow chloride ions to flow into neurons, which stabilizes the cell and prevents it from firing too easily. Proper assembly and trafficking of these receptors to the synapse are vital for maintaining a balance between excitation and inhibition. Disruptions in this gene can lead to a loss of inhibitory function, which is why GABRG2 is a well-established focus in epilepsy research. When the 'brakes' of the brain are impaired, it can lower the threshold for seizures.
Research Associations and Evidence Strength
Research has established a strong link between pathogenic mutations in the GABRG2 gene and a spectrum of epilepsy syndromes, including genetic epilepsy with febrile seizures plus (GEFS+) and childhood absence epilepsy. While rare, highly disruptive mutations in this gene are known to cause significant clinical phenotypes. However, the evidence for common variants like rs6495446 is more nuanced. While the gene itself is a major player in seizure susceptibility, the specific association of rs6495446 with clinical outcomes is considered to have moderate evidence strength. It is important to distinguish between rare, high-impact mutations that directly cause disease and common variants that may only slightly modify risk or have no clinical impact at all. Current research continues to investigate whether this specific SNP contributes to the phenotypic heterogeneity observed in patients with epilepsy or if it serves as a neutral marker in the population.
Population Frequency
The rs6495446 variant is classified as a common variant, meaning it is found at a relatively high frequency across various global populations. In genomic databases, common variants are those that appear in a significant percentage of the population, often making them useful for broad genetic mapping studies. Because it is common, most individuals will carry at least one copy of the variant, and it is not restricted to any single ancestral group. This high frequency suggests that the variant is likely a normal part of human genetic diversity rather than a rare, disease-causing mutation. Researchers often use common variants to understand the baseline genetic landscape, but their presence in the general population means they are rarely the sole cause of complex medical conditions.
What You Can and Cannot Do With This Information
Information about genetic variants like rs6495446 is intended for educational purposes and to provide insight into the biological mechanisms of the human body. It is crucial to understand that having a specific genotype for a common variant does not constitute a medical diagnosis. Genetic associations are statistical in nature and do not predict individual health outcomes with certainty. If you are concerned about a family history of seizures or epilepsy, or if you have questions about your own health, you should consult with a qualified healthcare professional or a genetic counselor. They can provide context based on your personal medical history and clinical testing, which is far more informative than looking at a single SNP in isolation. Never use genetic data to make decisions about medication or treatment without direct guidance from your clinician.
How common is this variant?
The rs6495446 variant is common across diverse ancestral populations, appearing frequently in global genomic datasets.
Frequently asked questions
Is rs6495446 a cause of epilepsy?
No, rs6495446 is a common genetic variant and is not considered a direct cause of epilepsy. While the GABRG2 gene is associated with epilepsy, rare, high-impact mutations are typically the cause of genetic epilepsy syndromes, not common SNPs.
Should I get tested for this variant?
There is generally no clinical utility in testing for common variants like rs6495446. Genetic testing for epilepsy is usually reserved for identifying rare, pathogenic mutations in a clinical setting under the guidance of a neurologist.
What does 'common variant' mean?
A common variant is a genetic change that occurs in a significant portion of the population. These variants are usually considered part of normal human genetic diversity and are rarely the sole cause of disease.
Can I change my risk based on this genotype?
Because this is a common variant with no established clinical impact, there is no action to take. You should focus on general health and wellness, and consult a doctor for any specific medical concerns.
Sources & further reading
Educational information only, last refreshed 9/19/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs6495446?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in GABRG2
This variant in the GABRG2 gene is associated with variations in response to certain anticonvulsant medications and epilepsy susceptibility.
This variant is located in the GABRG2 gene, which encodes the gamma-2 subunit of the GABA-A receptor; variants in this gene are associated with a spectrum of epilepsy syndromes.
Linked to GABA-A receptor subunit dysfunction, a known mechanism for inherited epilepsy syndromes.
A common variant in GABRG2, a gene encoding a GABA-A receptor subunit linked to various epilepsy phenotypes including febrile seizures and GEFS+.
Variant in GABRG2, a gene where mutations can alter GABA-A receptor function and influence seizure thresholds.
Mutations in GABRG2 are linked to a spectrum of epilepsy ranging from simple febrile seizures to severe developmental and epileptic encephalopathies.